Literature DB >> 25746662

High-mobility group box-1 gene, a potent proinflammatory mediators, is upregulated in more degenerated human discs in vivo and its receptor upregulated by TNF-α exposure in vitro.

Helen E Gruber1, Gretchen L Hoelscher2, Synthia Bethea2, Jane Ingram2, Michael Cox2, Edward N Hanley2.   

Abstract

Mechanisms which control and enhance proinflammatory cytokine expression during human disc degeneration are still poorly understood. The high-mobility group box-1 gene (HMGB1) produces a protein which can itself act as a cytokine, or can function as a potent proinflammatory mediator. Little is known about expression of HMGB1 in the human disc. Since proinflammatory cytokines increase significantly during human disc degeneration, in this work we hypothesized that HMGB1 may show upregulation with advancing stages of degeneration, and upregulation in cells exposed to TNF-α. Immunohistochemistry was performed to confirm the presence of HMGB1 in the human disc, and human annulus cells were cultured and challenged with 10(3)pM TNF-α for 14days in 3D culture. Cells with positive HMGB1 immunolocalization were abundant in the outer annulus. Molecular analysis of cultured cells showed an 8-fold significant increase in HMGB1 expression in more degenerated Thompson grade V discs compared to healthier grade I/II discs (p=0.033). Human disc tissue was assessed in molecular studies. Herniated specimens showed a 6.3-fold significantly greater expression level than that seen in control specimens (p=0.001). In culture experiments, expression of the receptor to HMGB1, toll-like receptor 2, showed a 24-fold upregulation in vitro in cells exposed to TNF-α vs. controls (p=0.0003).
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disc degeneration; HMGB1; Proinflammatory cytokines; TNF-α

Mesh:

Substances:

Year:  2015        PMID: 25746662     DOI: 10.1016/j.yexmp.2015.03.001

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  7 in total

1.  Nerve Growth Factor Is Regulated by Toll-Like Receptor 2 in Human Intervertebral Discs.

Authors:  Emerson Krock; J Brooke Currie; Michael H Weber; Jean A Ouellet; Laura S Stone; Derek H Rosenzweig; Lisbet Haglund
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

2.  miR-142-3p and HMGB1 Are Negatively Regulated in Proliferation, Apoptosis, Migration, and Autophagy of Cartilage Endplate Cells.

Authors:  Bo Wang; Demin Ji; Wenhua Xing; Feng Li; Zhi Huang; Wenkai Zheng; Jianmin Xue; Yong Zhu; Xuejun Yang
Journal:  Cartilage       Date:  2021-05-06       Impact factor: 3.117

3.  MicroRNA-142-3p inhibits hypoxia/reoxygenation‑induced apoptosis and fibrosis of cardiomyocytes by targeting high mobility group box 1.

Authors:  Yi Wang; Min Ouyang; Qiong Wang; Zaijin Jian
Journal:  Int J Mol Med       Date:  2016-09-28       Impact factor: 4.101

4.  Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells.

Authors:  Juan Ji; Ting Fu; Chen Dong; Wenyan Zhu; Junling Yang; Xiaoli Kong; Zhongyuan Zhang; Yanfeng Bao; Rui Zhao; Xinyu Ge; Xiaoqi Sha; Zhimin Lu; Jing Li; Zhifeng Gu
Journal:  Aging (Albany NY)       Date:  2019-07-14       Impact factor: 5.682

5.  IL-1β/HMGB1 signalling promotes the inflammatory cytokines release via TLR signalling in human intervertebral disc cells.

Authors:  Fang Fang; Dianming Jiang
Journal:  Biosci Rep       Date:  2016-09-16       Impact factor: 3.840

6.  Toll-like Receptor Activation Induces Degeneration of Human Intervertebral Discs.

Authors:  Emerson Krock; Derek H Rosenzweig; J Brooke Currie; Daniel G Bisson; Jean A Ouellet; Lisbet Haglund
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

7.  Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cells.

Authors:  Chi-Chien Niu; Song-Shu Lin; Li-Jen Yuan; Meng-Ling Lu; Steve W N Ueng; Chuen-Yung Yang; Tsung-Ting Tsai; Po-Liang Lai
Journal:  Arthritis Res Ther       Date:  2019-01-31       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.